Dr. Zenovia Spot Treatment

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dr. Zenovia Spot Treatment
Generic name: BENZOYL PEROXIDE
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: dfdb3d8e-4d39-4ce4-851f-80b11972ca9e
SPL ID: 470d894e-af84-4370-880c-16725870d808
Version: 2
Effective date: 2024-06-11
Source export date: 2026-11-06
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/7dfa569f2d8f065241260fd9a4886d0ef0a3120fd6ee31d6d07c234e689e8c91/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
Import run: 20261106T075659Z
Imported at: 2026-11-06 08:20:14

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Dr. Zenovia Spot Treatment	openfda.brand_name
generic name		BENZOYL PEROXIDE	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-802-01	openfda.package_ndc
ndc	product	51326-802	openfda.product_ndc
ndc11	package	51326080201	derived:openfda.package_ndc
rxcui		1488689	openfda.rxcui
spl id		470d894e-af84-4370-880c-16725870d808	id
spl set id		dfdb3d8e-4d39-4ce4-851f-80b11972ca9e	set_id
unii		W9WZN9A0GM	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid contact with eyes. If contact occurs, flush thoroughly with water. Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.